tirzepatide compound headache Unanticipated Adverse Events With Tirzepatide: Three Cases Underscoring the Importance of Postmarketing Monitoring Does Tirzepatide Cause Headaches? 6

late 2027 at the earliest, and more likely 2028

The FDA's pharmacovigilance system continues monitoring adverse event reports for all GLP-1 medications, and no formal warning has been issued specifically linking semaglutide or tirzepatide to appendicitis as a class effect

FA, particularly to ultra-processed foods, can be a significant driver of maladaptive behaviors toward progressively worsening symptoms ( Recently, there has been an increased awareness of FA and the need for effective interventions

Although clinical trials have not identified unexpected pancreatitis signals with Retatrutide, clinicians should remain vigilant for persistent abdominal pain, particularly during dose escalation